Charles Bennett to Benzamides
This is a "connection" page, showing publications Charles Bennett has written about Benzamides.
Connection Strength
0.206
-
Geography: an increasingly important variable in prostate cancer clinical trials. BJU Int. 2015 Jan; 115(1):2-3.
Score: 0.107
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
Score: 0.072
-
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guideline. J Clin Oncol. 2014 Oct 20; 32(30):3436-48.
Score: 0.026